Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:57:31 EDT Mon 29 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:ATAI
- ATAI LIFE SCIENCES NV -
http://www.ata.net.cn
14:57:31 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
ATAI
- Q
1.1
1.99
·
2.00
3.4
1.99
+0.06
3.1
974.0
1,788
2,132
1.89
2.05
1.88
2.85 1.025
14:37:32
Apr 24
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 2132
More trades...
Time ET
Ex
Price
Change
Volume
14:37:32
Q
1.995
0.065
2
14:37:07
Q
1.995
0.065
12
14:37:07
Q
1.995
0.065
8
14:36:34
Q
1.99
0.06
100
14:36:34
Q
1.99
0.06
1,000
14:36:34
Q
1.99
0.06
1
14:36:34
Q
1.99
0.06
1
14:36:18
Q
1.99
0.06
100
14:36:10
Q
1.98
0.05
10
14:35:41
Q
1.9869
0.0569
250
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-24 07:01
U:ATAI
News Release
200
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech's Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
2024-04-17 07:00
U:ATAI
News Release
200
atai Life Sciences Announces the Publication of Beckley Psytech's Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
2024-03-28 07:00
U:ATAI
News Release
200
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
2024-03-27 07:01
U:ATAI
News Release
200
atai Life Sciences Announces Positive Initial Results from Beckley Psytech's Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
2024-03-12 12:36
U:ATAI
News Release
200
atai Life Sciences advances VLS-01 for treatment-resistant depression
2024-03-04 08:00
U:ATAI
News Release
200
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
2024-02-28 17:00
U:ATAI
News Release
200
atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
2024-02-06 17:01
U:ATAI
News Release
200
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
2024-01-04 07:00
U:ATAI
News Release
200
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
2024-01-02 08:00
U:ATAI
News Release
200
atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
2023-11-14 07:03
U:ATAI
News Release
200
atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
2023-10-10 08:00
U:ATAI
News Release
200
ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT
2023-10-06 16:05
U:ATAI
News Release
200
atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
2023-10-02 16:13
U:ATAI
News Release
200
atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 ‚ in Healthy Participants
2023-09-14 08:02
U:ATAI
News Release
200
atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
2023-09-06 16:01
U:ATAI
News Release
200
atai Life Sciences to Participate in Upcoming September Investor Conferences
2023-08-10 06:59
U:ATAI
News Release
200
atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)
2023-08-08 16:02
U:ATAI
News Release
200
atai Life Sciences Announces Results ‚ from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
2023-06-01 09:10
U:ATAI
News Release
200
Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer
2023-06-01 06:59
U:ATAI
News Release
200
atai Life Sciences to Participate in Upcoming June Investor Conferences